Peptide Research

GHK-Cu is a naturally occurring copper-binding tripeptide first identified in human plasma by Loren Pickart in 1973. It is found in blood, saliva, and urine, with plasma levels declining from about 200 ng/mL at age 20 to 80 ng/mL by age 60. The copper ion is essential for its biological activity, as it enables the peptide to serve as a bioavailable copper delivery system.

GHK-Cu exerts its biological effects through multiple well-characterized mechanisms. It powerfully stimulates collagen synthesis (types I and III), decorin, and glycosaminoglycan production in dermal fibroblasts. Simultaneously, it upregulates matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), enabling coordinated tissue remodeling rather than simple collagen deposition. This remodeling capacity is key to its wound-healing effects — GHK-Cu promotes organized tissue repair rather than scar formation.

Beyond structural matrix effects, GHK-Cu has potent antioxidant activity via SOD and glutathione pathway upregulation, suppresses inflammatory cytokines including TGF-beta and TNF-alpha, and promotes angiogenesis by inducing VEGF and FGF-2 expression. Gene expression studies by Pickart et al. using the Broad Institute Connectivity Map showed GHK can influence the expression of over 4,000 genes, with patterns suggesting suppression of fibrosis-related and inflammation-related gene networks.

Epitalon is a synthetic tetrapeptide based on the naturally occurring peptide epithalamin, which is extracted from the pineal gland. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, epitalon is the most extensively studied of the Khavinson peptide bioregulators. Its primary mechanism of action involves activation of telomerase, the enzyme responsible for maintaining telomere length at chromosome ends.

Telomeres shorten with each cell division, and this progressive shortening is considered a key hallmark of cellular aging. When telomeres become critically short, cells enter senescence or undergo apoptosis. Khavinson and colleagues demonstrated that epitalon can activate telomerase in human somatic cells, leading to elongation of telomeres and extension of cellular lifespan beyond the Hayflick limit. This was shown in human fetal fibroblast cultures where epitalon-treated cells underwent significantly more population doublings than controls.

Epitalon also influences melatonin production. As a pineal bioregulator, it has been shown to restore the nocturnal melatonin peak in aged primates, which normally declines with age. This melatonin-related activity provides a secondary mechanism through which epitalon may affect aging processes, given melatonin's roles as an antioxidant and circadian regulator.